Related Experiment Video
Updated: May 8, 2026
Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts
Published on: March 2, 2017
Comparison of three luteal phase support in cases with modified natural cycles cases undergoing euploid blastocyst
Sevinc Ozmen1, Gonul Ozer1, Ipek Nur Balın Duzguner1
1Memorial Sisli Hospital, ART and Reproductive Genetics Center, Istanbul, Turkey.
Objective:
The aim was to investigate whether the use of progesterone during the luteal phase improves the live birth rate (LBR) of euploid embryos in modified natural frozen-thawed embryo transfer (mNC-FET) cycles. The primary outcome measure was the live birth rate.
Methods:
Retrospective cohort study. Istanbul Memorial Hospital, ART and Reproductive Genetics Center. Patients who underwent single vitrified-warmed euploid blastocyst transfer in mNC/FET cycle between January 2014 and May 2023. Without progesterone LPS-WP [n=418], with vaginal P LPS-VP [n=1995] (gel 90 mgx 2/d up to November 2020 then vag P 100 mgx2/d), with vaginal + subcutaneous P 25 mg/d LPS-VP+SC[n=789].
Results:
The 3 groups were comparable for basal characteristics. The live birth rate, the primary outcome, was significantly higher in both the LPS-VP [67.7 %] and LPS-VP+SC [67.7 %] groups compared to the LPS-WP group [59.1 %], with p = 0.002. Biochemical pregnancy rates were also significantly higher in the LPS-VP [80.3 %] and LPS-VP+SC [79.2 %] groups than in the LPS-WP group [70.8 %, p = 0.002]. Similarly, clinical pregnancy rates were higher in the LPS-VP [73.7 %] and LPS-VP+SC [71.6 %] groups compared to LPS-WP [65.1 %, p = 0.002]. Ongoing pregnancy rates followed the same pattern, with LPS-VP [69.3 %] and LPS-VP+SC [68.6 %] significantly outperforming LPS-WP [60.5 %, p = 0.002].
Conclusion:
In cases undergoing euploid embryo transfer in mNC/FET cycle vaginal progesterone supplementation has been shown to enhance rates of implantation, clinical pregnancy, and live births compared to those who do not receive progesterone supplementation. In our study, multivariable regression analysis revealed that progesterone supplementation during the luteal phase is significantly associated with an increased likelihood of live birth among infertile women However, administering progesterone subcutaneously alongside vaginal progesterone does not offer any additional advantages.
